Deep Vein Thrombosis
📧 Sign up to get email alerts when something new happens for Deep Vein Thrombosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Geko™ Plaster Cast Study, Deep Vein Thrombosis (DVT) Prophylaxis [EARLY_Phase 1]
An early-phase 1 trial evaluating the Geko Plaster Cast for DVT prophylaxis has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism [Phase 3]
Phase 3 study evaluating the efficacy and safety of apixaban for extended treatment of deep vein thrombosis or pulmonary embolism; results p…
-
FDA approval · 2013-10-22FDA Approved: FRAGMIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA page indicates Pfizer's supplemental application for FRAGMIN (dalteparin sodium) under NDA 020287 is under consideration for a supplemen…
-
CLINICAL_TRIALS trial_result · 2013-10-09Clinical Trial Update: Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients [Phase 4]
Clinical trial update describes Phase 4 evaluation of pharmacogenetics-guided warfarin dosing in Chinese patients.
-
FDA approval · 2013-09-12FDA Approved: ARIXTRA — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for ARIXTRA (fondaparinux sodium) submitted by Mylan Institutional LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information [NA]
This completed clinical trial aimed to develop a nomogram that incorporates clinical and genetic information to predict outcomes, focusing o…
-
CLINICAL_TRIALS research · 2013-07-19Clinical Trial Update: The Risk of Venous Clotting in Patients After Renal Transplant
This ClinicalTrials.gov entry describes a study on the risk of venous clotting in renal transplant recipients, sponsored by St. Joseph's Hea…
-
FDA approval · 2013-06-05FDA Approved: ENOXAPARIN SODIUM — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for enoxaparin sodium (Lovenox) from Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation. [Phase 4]
A Phase 4 clinical trial investigating whether enoxaparin reduces the incidence of deep vein thrombosis after electrophysiology studies and …
-
FDA approval · 2013-05-20FDA Approved: HEPARIN SODIUM — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Hospira's heparin sodium, indicating a modification to the product's approval (likely labeling o…
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: Safety Study of the Angel™ Catheter in Subjects With Risk of Pulmonary Embolism [Phase 1]
Phase 1 safety study of the Angel Catheter in subjects at risk of pulmonary embolism has completed, with results posted in 2013 by BiO2 Medi…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein Thrombosis [NA]
A completed clinical trial compared different intermittent pneumatic compression devices for deep vein thrombosis, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2) [Phase 2]
Phase 2 trial ONYX-2 evaluating YM150, a Factor Xa inhibitor by Astellas, for prevention of venous thromboembolism after hip replacement; th…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity
A completed clinical trial evaluated the accuracy and precision of the INRatio Prothrombin Time monitoring system using a new low-volume, he…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Early Detection of PICC-related Deep Vein Thrombosis by US Surveillance: an Effective Approach for Secondary Prevention?
A completed clinical trial from the University of Turin evaluated ultrasound surveillance for early detection of PICC-related deep vein thro…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Neuromuscular Electrical Stimulation Following Total Hip Arthroplasty [NA]
This document reports a completed clinical trial evaluating neuromuscular electrical stimulation following total hip arthroplasty.
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Treatment of Upper Extremity Deep-Vein Thrombosis [Phase 4]
Phase 4 trial evaluating treatment of upper extremity deep vein thrombosis has completed. Results were posted on February 4, 2013.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study [Phase 3]
The Phase 3 EINSTEIN DVT trial evaluated rivaroxaban for the treatment of acute symptomatic deep vein thrombosis; results were posted in 201…
-
FDA approval · 2013-01-10FDA Approved: HEPARIN SODIUM IN SODIUM CHLORIDE — Supplemental Application (B. Braun Medical Inc.)
FDA approves a supplemental application for HEPARIN SODIUM IN SODIUM CHLORIDE from B. Braun Medical Inc., expanding its labeling for anticoa…
-
FDA approval · 2012-12-19FDA Approved: PRADAXA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals Inc.)
FDA approved a supplemental application for Pradaxa (dabigatran etexilate mesylate) from Boehringer Ingelheim Pharmaceuticals Inc., to modif…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures [Phase 2, Phase 3]
A Phase 2/Phase 3 trial is evaluating thromboprophylaxis for patients with below-knee plaster immobilization after ankle/foot fractures to p…
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm [Phase 4]
Phase 4 clinical trial comparing warfarin dosing using a decision-model approach versus a pharmacogenetic algorithm; results were posted in …
-
FDA approval · 2012-11-02FDA Approved: XARELTO — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for XARELTO (rivaroxaban) filed by Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery [Phase 3]
Phase 3 trial evaluating fondaparinux for the prevention of venous thromboembolism in patients with immobilization after a below-knee injury…
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE) [Phase 3]
Phase III trial comparing dabigatran etexilate with warfarin for six months of treatment in acute symptomatic venous thromboembolism has com…